By interfering with ITGβ1, Src, or Cav1 activation we eliminated both the ability of TF/FVIIa to rescue cancer cells from TRAIL-induced apoptosis and the ability to induce IGF-1R-dependent protein production. The gene discussed is TF; the disease is cancer.